Ipca Laboratories gains on bagging award for supply of anti-malarial medicines

13 Nov 2017 Evaluate

Ipca Laboratories is currently trading at Rs. 592.10, up by 10.75 points or 1.85% from its previous closing of Rs. 581.35 on the BSE.

The scrip opened at Rs. 584.00 and has touched a high and low of Rs. 594.10 and Rs. 584.00 respectively.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 656.00 on 05-Apr-2017 and a 52 week low of Rs. 400.00 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 594.10 and Rs. 521.15 respectively. The current market cap of the company is Rs. 7,470.00 crore.

The promoters holding in the company stood at 46.13%, while Institutions and Non-Institutions held 38.81% and 15.06% respectively.

Ipca Laboratories has been selected by The Global Fund as their Panel Supplier of anti-malarial medicines for the Global Fund Pooled Procurement Mechanism and for the Private Sector Co-Payment Mechanism for an initial period of three years.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.


Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×